Bart Ben Sanford - 01 Mar 2023 Form 4 Insider Report for Inogen Inc (INGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Mar 2023, 19:46:37 UTC
Prior SEC filing
05 Dec 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leslyn Cicekli, as Attorney-in-Fact

Key filing fact

Bart Ben Sanford filed Form 4 for Inogen Inc (INGN) on 02 Mar 2023.

Key facts

  • This page summarizes Bart Ben Sanford's Form 4 filing for Inogen Inc (INGN).
  • 7 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 02 Mar 2023, 19:46.

Change

  • Previous filing in this sequence was filed on 05 Dec 2022.
  • Current net transaction value: -$26,032.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INGN transaction

Common Stock

Award

Transaction value
$0
Shares
+1,135
Change %
+12%
Price
$0.000000
Shares after
10,531
Date
01 Mar 2023
Ownership
Direct
Footnotes
F1
INGN transaction

Common Stock

Tax liability

Transaction value
$7,889
Shares
-507
Change %
-4.8%
Price
$15.56
Shares after
10,024
Date
01 Mar 2023
Ownership
Direct
Footnotes
F2
INGN transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+2,402
Change %
+24%
Price
$0.000000
Shares after
12,426
Date
01 Mar 2023
Ownership
Direct
INGN transaction

Common Stock

Tax liability

Transaction value
$18,143
Shares
-1,166
Change %
-9.4%
Price
$15.56
Shares after
11,260
Date
01 Mar 2023
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-273
Change %
-20%
Price
$0.000000
Shares after
1,092
Date
01 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
273
Exercise price
Footnotes
F4, F5
INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-236
Change %
-11%
Price
$0.000000
Shares after
1,881
Date
01 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
236
Exercise price
Footnotes
F4, F6
INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-1,893
Change %
-33%
Price
$0.000000
Shares after
3,787
Date
01 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,893
Exercise price
Footnotes
F4, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

The reported securities represent shares earned and vested on March 1, 2023 based on achievement of the financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on March 1, 2022.

Footnote F2

The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2022 performance-based restricted stock award granted on March 1, 2022 and vested on March 1, 2023.

Footnote F3

The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2023.

Footnote F4

Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

Footnote F5

Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

Footnote F6

Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

Footnote F7

Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .